The planning committee would like to thank our generous exhibitors for their support of the conference. An important aspect of the Geriatric Behavioral Health Conference is connecting you with services and resources that can help improve your patient care. Please browse the exhibitor profiles to learn more about each organization.
Breakout room bingo: visit the exhibitor breakout rooms to learn about their services and ask any questions you may have. Each exhibitor will provide you with a code word that you will enter into the space provided on the PDF.
Website treasure hunt: search each exhibitor's website for the answers to the questions throughout the PDF. Space is provided within the document to write your answers.
Save your completed PDF or take a screenshot, and send your documents to email@example.com by Sunday, October 4. Participants that submit their fully completed questionnaire by this date will be entered into the respective drawings described below. Winners will be contacted via email with more information.
To incentivize engagement with exhibitors, participants who complete the:
- Website treasure hunt will be entered into a drawing for four (4) half-off registrations for the 5th Annual Geriatric Behavioral Health Conference.
- Breakout room bingo will be entered into a drawing for two (2) complimentary registrations for the 5th Annual Geriatric Behavioral Health Conference.
Currently, patients, caregivers, and families are dealing with the impact of COVID-19 on their physical and mental health. Providers have shared that some Parkinson’s patients are dealing with a higher level of stress and anxiety due to the pandemic. Social isolation and long hours at home may also have magnified or exacerbated some of the symptoms of Parkinson’s Hallucinations and Delusions.
NUPLAZID® (pimavanserin) is the only medicine FDA-approved to reduce the frequency and/or severity of hallucinations and delusions associated with Parkinson’s disease psychosis. Please visit our website for more information about how you can improve your patients' quality of life.
Iowa's medical cannabis program recently updated!
Gov. Reynolds made significant improvements to the program in July 2020 by adding additional certifiers. ARNPs, PAs, and Podiatrists are now able to sign patient applications. Other big updates added are new approved conditions such as chronic pain (arthritis for example) and PTSD, as well as removal of the 3% THC cap allowing for new product formulations such as THC vapes.
Learn more about Iowa's Medical Cannabis program, including provider FAQs and how to get a card, by visiting the MedPharm Iowa website.
The vision of Neurocrine Biosciences is to relieve patient suffering and enhance lives. We are a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. Our diverse portfolio includes FDA-approved treatments for disorders such as tardive dyskinesia and Parkinson’s disease. Learn more about these treatment options by visiting the links below.
The Association for Frontotemporal Degeneration (AFTD) is the leading nonprofit working to improve the quality of life of people affected by frontotemporal degeneration (FTD) and drive research to bring hope for a world with compassionate care, effective support, and a future free of this disease.
We work every day to advance collaborative research, help and support all individuals directly impacted by FTD, raise awareness, and educate healthcare professionals while advocating for appropriate, affordable services.